Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Acute Card Care ; 10(4): 221-6, 2008.
Article in English | MEDLINE | ID: mdl-18720086

ABSTRACT

Intracardiac thrombi are well known complications associated with diverse cardiac diseases and venous thromboembolism. Therapeutic recommendations like thrombolysis, surgical thrombectomy, or treatment with low molecular heparin and intravenous unfractionated heparin based on small numbers of patients or retrospective case series have failed to reach a consensus. We report on the use of argatroban, a new direct thrombin inhibitor in 4 patients with intracardiac thrombi. Therapy was effective in all patients with complete resolution of thrombi. Treatment was complicated by recurrent strokes with complete neurological recovery in one patient. Therapy of intracardiac thrombi by argatroban is safe and effective. The drug requires no dosage adjustments for age, sex, or renal impairment, including in dialysis-dependent patients. Argatroban has been found to increase predictably activated partial thromboplastin time (aPTT) and activated clotting time (ACT) in a dose-dependent manner.


Subject(s)
Anticoagulants/therapeutic use , Pipecolic Acids/therapeutic use , Platelet Aggregation Inhibitors/therapeutic use , Thrombosis/drug therapy , Adult , Aged , Aged, 80 and over , Anticoagulants/administration & dosage , Arginine/analogs & derivatives , Female , Heart Diseases/drug therapy , Humans , Male , Middle Aged , Partial Thromboplastin Time/methods , Pipecolic Acids/administration & dosage , Sulfonamides , Treatment Outcome , Whole Blood Coagulation Time/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...